written on 28.03.2014

Regeneron clears roadblock for new plant in Irish tax haven


Regeneron will continue forth with its €220 million plans to revamp a former Dell plant in Ireland now that an interest group has pulled its appeal, making room to flesh out its product line beyond blazing eye treatment Eylea.